CutisCare SHS, LLC – Trademark Portfolio
Entity Type: 16
CutisCare SHS, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CAREACCEL, REGENQUEST, and 2 HYPERBARIC AWARE. The owner is based in Boca Raton, FL.
Suite 100E
2300 Glades Road
Boca Raton, FL 33431
Showing of trademarks Trademarks
Trademark Classifications
CutisCare SHS, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CutisCare SHS, LLC have?
CutisCare SHS, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned.
What trademark classes does CutisCare SHS, LLC file in?
CutisCare SHS, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are CutisCare SHS, LLC's most well-known trademarks?
CutisCare SHS, LLC's registered trademark portfolio includes well-known marks such as CAREACCEL, REGENQUEST, and 2 HYPERBARIC AWARE. These are among 4 currently registered trademarks in the portfolio.
What is CutisCare SHS, LLC's trademark registration success rate?
CutisCare SHS, LLC has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.